Edwyn logo

Edwyn

Find Companies
Find Companies
Dashboard
Find Companies...

Footer

EdwynEdwyn

Conduct a Professional Comparative analysis in seconds. Empowering your financial decisions with data-driven insights.

Subscribe to our newsletter

Company

  • About
  • Contact us
  • Register

Legal

  • Privacy
  • Terms

Guides

  • What is Enterprise Value?
  • How much is my company worth?

© 2025 Edwyn, LLC. All rights reserved.

Edwyn logo

Edwyn

Enterprise Value
EV Calculator
Help
What is Enterprise Value?
    Log in
    Log in
    Tesla, Inc.
    Apple Inc.
    NVIDIA
    Walmart
    Microsoft
    No valuations found.
    Log in to save
    Edwyn logo

    Edwyn

    Tesla, Inc.
    Apple Inc.
    NVIDIA
    Walmart
    Microsoft
    No valuations found.
    QUEST DIAGNOSTICS INC (DGX)
    Income
    Balance Sheet
    Market Cap
    $29B
    Latest price
    $181.18
    -1.59%
    Dollar Amounts
    USD (Millions)
    Metric20202021202220232024
    Revenue$9,437$10,788$9,883$9,252$9,872
    Gross Profit$3,633$4,209$3,433$3,053$3,244
    Operating Income$1,971$2,381$1,428$1,262$1,346
    Net Income$1,431$1,995$946$854$871
    Showing latest financials
    Data in millions of USD
    Doing some research...

    Commentary on Quest Diagnostics Inc Performance

    Over the five-year period, Quest Diagnostics Inc. demonstrated mixed financial performance. In 2020, the company reported revenues of $9.44 billion, which surged by nearly 14% to $10.79 billion in 2021. This revenue growth was accompanied by improvements in gross profit and operating income, increasing from $3.63 billion and $1.97 billion in 2020 to $4.21 billion and $2.38 billion in 2021, respectively. However, the subsequent years have seen marked declines. Revenues dropped by roughly 8% in 2022 to $9.88 billion and further declined by 6% in 2023 to $9.25 billion. A modest recovery occurred in 2024, with revenues rebounding to $9.87 billion. Similar trends are evident in gross profit, which fell by approximately 19% from 2021 to 2022, and operating income, which decreased significantly—over 40% from 2021’s level—indicating substantial cost pressures or operational challenges. The net income trend is particularly stark, as it increased from $1.43 billion in 2020 to $1.99 billion in 2021, then experienced a dramatic decline to $946 million in 2022, a change exceeding 50%, and continued to deteriorate through 2023 and 2024. These substantial year-over-year swings, especially the drop from 2021 to 2022, suggest that the business may have faced external market pressures, shifts in demand, or operational inefficiencies impacting profitability. Within the competitive and highly regulated healthcare diagnostics industry, such volatility underscores the need for Quest Diagnostics to manage costs and adapt to market dynamics effectively. Overall, while the company’s recovery in revenue and modest stabilization toward 2024 indicate resilience, the significant declines in profit margins raise concerns regarding its operational sustainability and highlight areas requiring strategic attention.

    This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.